Veterinary researcher validates human tracheal/bronchial-cell model for influenza A infections of trachea

March 16, 2015 by Joe Montgomery, Kansas State University
A. Sally Davis has joined Kansas State University's College of Veterinary Medicine as a veterinary pathologist.

A recently hired veterinary pathologist is bringing multiple skills to her new position in the College of Veterinary Medicine at Kansas State University, including experience with a human primary cell line used for modeling human influenza infections.

A. Sally Davis is an assistant professor of in the diagnostic medicine and pathobiology department. Part of her appointment at Kansas State University is to provide pathology support to the Department of Homeland Security's Center of Excellence for Emerging Zoonotic Animal Diseases at the university.

Davis graduated in 2014 from the National Institutes of Health Comparative Biomedical Scientist Training Program in partnership with North Carolina State University. At the NIH, she conducted her doctoral research under Dr. Jeffery K. Taubenberger in the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Diseases. Her work was funded through the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. Her research has produced a paper on an in vitro model for influenza infections that will be published in May's Journal of Histochemistry & Cytochemistry.

"This is a human cell line that has been in use for quite a while in respiratory research," Davis said. "However, there was no detailed comparison of the epithelium that these cells can form in the laboratory to their source tissue, the human trachea. Therefore, the idea was to perform morphological comparisons as well as study differences in response to influenza infection of the 'pseudo' trachea versus human trachea sampled from autopsy material, including individuals who died from an influenza infection. We found that the model was particularly strong at early infection time points, but has limitations at later time points."

The results will enable respiratory virus researchers to better interpret data generated with this system. Additionally, this type of research provides an approach to validation of other in vitro models derived from other animal species.

"It is important to know both the strengths and limitations of these models so that scientific findings may be accurately interpreted," Davis said.

Part of the research used electron microscopy and immunofluorescence confocal microscopy, which are areas of expertise Davis will use at Kansas State University. She said she will present guest lectures and assist in collaborative research projects using the microscopy facilities.

Davis also will present a paper on the 1918 pandemic influenza—Spanish flu—at the Experimental Biology conference in Boston at the end of March. For this work, Davis has won the Histochemical Society-sponsored American Society of Investigative Pathology travel award and has been invited to co-chair the "Microbial Interactions with the Host" mini symposium at the conference.

In her research, Davis said she enjoys working with and mentoring students. At the Kansas State University she anticipates working with both undergraduate and Doctor of Veterinary Medicine students, including publishing with students on future research papers.

"I was originally a high school biology teacher, so I've always had a strong interest in working with students," Davis said. "Even while I was working on my own Doctor of Veterinary Medicine at North Carolina State University, I formally tutored some of my classmates. During, my residency training, I mentored DVM students in pathology and research projects."

While much of her recently published work has involved primarily human applications, Davis chose to return to a environment so that she could better focus on the animal-human interface of . She looks forward to working on nonhuman projects, such as vaccine efficacy studies in swine and sheep, and building new collaborations at the university while she continues her previous collaborations with the NIH.

Explore further: Researchers monitor for next novel influenza strain

More information: "Validation of Normal Human Bronchial Epithelial Cells as a Model for Influenza A Infections in Human Distal Trachea" J Histochem Cytochem 0022155415570968, first published on January 20, 2015 DOI: 10.1369/0022155415570968

Related Stories

Researchers monitor for next novel influenza strain

March 4, 2015
As seasonal influenza cases decrease across the United States, Kansas State University researchers are preparing for the next potential virulent strain of flu.

Study finds potential treatment for drug-resistant H7N9 influenza virus

January 16, 2014
The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping ...

Researchers find bat influenza viruses unlikely threaten human health

October 30, 2014
Bats seen at Halloween this year may not be quite as scary as they appear – at least when it comes to the spread of specific viruses. A research project conducted in part by a team of researchers in the College of Veterinary ...

Epidemiologist publishes model on the impact of a regional foot-and-mouth disease outbreak

December 9, 2014
A research project in the Kansas State University College of Veterinary Medicine presents the largest model to date for evaluating the impact and control of a potential outbreak of foot-and-mouth disease in livestock.

PREDICT program a model for global pandemic prevention

November 30, 2012
(Medical Xpress)—Groundbreaking efforts by PREDICT, a project led by the One Health Institute at the University of California, Davis, are highlighted today in the medical journal The Lancet as a model for a new, globally ...

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.